Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Prepaid Assets (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Prepaid Assets for 7 consecutive years, with $21.4 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 59.52% to $21.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Dec 2025, up 59.52% year-over-year, with the annual reading at $21.4 million for FY2025, 59.52% up from the prior year.
  • Prepaid Assets hit $21.4 million in Q4 2025 for IDEAYA Biosciences, up from $15.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $21.4 million in Q4 2025 to a low of $2.8 million in Q1 2022.
  • Historically, Prepaid Assets has averaged $8.6 million across 5 years, with a median of $7.1 million in 2023.
  • Biggest five-year swings in Prepaid Assets: fell 23.48% in 2022 and later skyrocketed 162.84% in 2024.
  • Year by year, Prepaid Assets stood at $3.1 million in 2021, then skyrocketed by 73.36% to $5.4 million in 2022, then skyrocketed by 38.53% to $7.5 million in 2023, then skyrocketed by 78.59% to $13.4 million in 2024, then skyrocketed by 59.52% to $21.4 million in 2025.
  • Business Quant data shows Prepaid Assets for IDYA at $21.4 million in Q4 2025, $15.8 million in Q3 2025, and $15.9 million in Q2 2025.